
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Psychotropic Drug–Related Weight Gain and Its Treatment
Roger S. McIntyre, Angela T.H. Kwan, Joshua D. Rosenblat, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 26-38
Closed Access | Times Cited: 35
Roger S. McIntyre, Angela T.H. Kwan, Joshua D. Rosenblat, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 26-38
Closed Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas
Roger S. McIntyre
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 5, pp. 539-542
Open Access | Times Cited: 12
Roger S. McIntyre
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 5, pp. 539-542
Open Access | Times Cited: 12
Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic review
Alexia Leber, Ranuk Ramachandra, Felicia Ceban, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 4, pp. 467-476
Open Access | Times Cited: 8
Alexia Leber, Ranuk Ramachandra, Felicia Ceban, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 4, pp. 467-476
Open Access | Times Cited: 8
Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review
Sebastian Badulescu, Aniqa Tabassum, Gia Han Le, et al.
Physiology & Behavior (2024) Vol. 283, pp. 114622-114622
Open Access | Times Cited: 8
Sebastian Badulescu, Aniqa Tabassum, Gia Han Le, et al.
Physiology & Behavior (2024) Vol. 283, pp. 114622-114622
Open Access | Times Cited: 8
Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression
Roger S. McIntyre, István Bitter, Jozefien Buyze, et al.
European Neuropsychopharmacology (2024) Vol. 85, pp. 58-65
Open Access | Times Cited: 5
Roger S. McIntyre, István Bitter, Jozefien Buyze, et al.
European Neuropsychopharmacology (2024) Vol. 85, pp. 58-65
Open Access | Times Cited: 5
Antidepressants and Weight Gain: An Update on the Evidence and Clinical Implications
Lauren Moss, Marci Laudenslager, Kristine J. Steffen, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access
Lauren Moss, Marci Laudenslager, Kristine J. Steffen, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access
Psychopharmakainduzierte Gewichtszunahme – sind Inkretine/Twinkretine eine Option?
Michael Paulzen
Der Nervenarzt (2025)
Closed Access
Michael Paulzen
Der Nervenarzt (2025)
Closed Access
Weight Stigma in Medicine
Jennifer Derenne
FOCUS The Journal of Lifelong Learning in Psychiatry (2025) Vol. 23, Iss. 1, pp. 49-52
Closed Access
Jennifer Derenne
FOCUS The Journal of Lifelong Learning in Psychiatry (2025) Vol. 23, Iss. 1, pp. 49-52
Closed Access
The Co-occurrence of Depression and Obesity
Roger S. McIntyre
The Journal of Clinical Psychiatry (2024) Vol. 85, Iss. 2
Open Access | Times Cited: 4
Roger S. McIntyre
The Journal of Clinical Psychiatry (2024) Vol. 85, Iss. 2
Open Access | Times Cited: 4
Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases
Hubertus Himmerich, Jessica Bentley, Susan L. McElroy
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 697-718
Closed Access | Times Cited: 4
Hubertus Himmerich, Jessica Bentley, Susan L. McElroy
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 697-718
Closed Access | Times Cited: 4
Pharmacotherapy of Weight‐loss and Obesity with a Focus on GLP 1‐Receptor Agonists
Merle Myerson, Rodis Paparodis
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 10, pp. 1204-1221
Closed Access | Times Cited: 3
Merle Myerson, Rodis Paparodis
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 10, pp. 1204-1221
Closed Access | Times Cited: 3
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase®)
Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat, et al.
Journal of Affective Disorders (2024)
Open Access | Times Cited: 3
Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat, et al.
Journal of Affective Disorders (2024)
Open Access | Times Cited: 3
Consensus on the key characteristics of metabolism disruptors
Michele A. La Merrill, Martyn T. Smith, Cliona M. McHale, et al.
Nature Reviews Endocrinology (2024)
Open Access | Times Cited: 3
Michele A. La Merrill, Martyn T. Smith, Cliona M. McHale, et al.
Nature Reviews Endocrinology (2024)
Open Access | Times Cited: 3
Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation
Aoife Carolan, Caroline Hynes, Sri Mahavir Agarwal, et al.
Schizophrenia Bulletin (2024)
Open Access | Times Cited: 3
Aoife Carolan, Caroline Hynes, Sri Mahavir Agarwal, et al.
Schizophrenia Bulletin (2024)
Open Access | Times Cited: 3
Association of Life’s Essential 8 with depression among adults: A cross-sectional study of NHANES
Yinyin Bai, Sanqin Guo
Journal of Investigative Medicine (2024) Vol. 72, Iss. 7, pp. 737-746
Closed Access | Times Cited: 2
Yinyin Bai, Sanqin Guo
Journal of Investigative Medicine (2024) Vol. 72, Iss. 7, pp. 737-746
Closed Access | Times Cited: 2
Psychotropic drugs, eating behaviour and weight gain
Shalika Arniotis-Streat, Anthony Fonte, Hisham Ziauddeen
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 5, pp. 331-336
Closed Access | Times Cited: 2
Shalika Arniotis-Streat, Anthony Fonte, Hisham Ziauddeen
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 5, pp. 331-336
Closed Access | Times Cited: 2
Body Image, Nutrition, and Mental Health
Hubertus Himmerich, Khadijeh Mirzaei
Nutrients (2024) Vol. 16, Iss. 8, pp. 1106-1106
Open Access | Times Cited: 1
Hubertus Himmerich, Khadijeh Mirzaei
Nutrients (2024) Vol. 16, Iss. 8, pp. 1106-1106
Open Access | Times Cited: 1
Tackling Cravings in Medical Weight Management: An Update on Pathophysiology and an Integrated Approach to Treatment
Naomi Kakoschke, Belinda A. Henry, Michael A. Cowley, et al.
Nutrients (2024) Vol. 16, Iss. 19, pp. 3238-3238
Open Access | Times Cited: 1
Naomi Kakoschke, Belinda A. Henry, Michael A. Cowley, et al.
Nutrients (2024) Vol. 16, Iss. 19, pp. 3238-3238
Open Access | Times Cited: 1
Bias related to overweight and obesity among French psychiatrists: Results of a national survey
Léonie Sohier, Marie-Sophie Ravet, Aurélie Berger-Vergiat, et al.
L Encéphale (2024)
Open Access | Times Cited: 1
Léonie Sohier, Marie-Sophie Ravet, Aurélie Berger-Vergiat, et al.
L Encéphale (2024)
Open Access | Times Cited: 1
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic review
Serene M. L. Lee, Maggie Li, Gia Han Le, et al.
Annals of General Psychiatry (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Serene M. L. Lee, Maggie Li, Gia Han Le, et al.
Annals of General Psychiatry (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
A systematic review on the efficacy of GLP-1 receptor agonists in mitigating psychotropic drug-related weight gain
T. U. K. Menon, Serene M. L. Lee, Xiaowen Gong, et al.
CNS Spectrums (2024) Vol. 29, Iss. 5, pp. 347-353
Open Access | Times Cited: 1
T. U. K. Menon, Serene M. L. Lee, Xiaowen Gong, et al.
CNS Spectrums (2024) Vol. 29, Iss. 5, pp. 347-353
Open Access | Times Cited: 1
Improving Clinical Outcomes and Informing New Interventions
Ned H. Kalin
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 1-3
Closed Access
Ned H. Kalin
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 1-3
Closed Access
EXPLORING THE EFFICACY AND FEASIBILITY OF LIFESTYLE INTERVENTIONS AND STRESS MANAGEMENT TECHNIQUES, IN MANAGING AND PREVENTING CARDIOVASCULAR DISEASES
Ayesha Aziz, Anurag Rawat, Razia Virk, et al.
(2024), pp. 241-250
Open Access
Ayesha Aziz, Anurag Rawat, Razia Virk, et al.
(2024), pp. 241-250
Open Access
Orlistat for the treatment of antipsychotic-induced weight gain: an eight-week multicenter, randomized, placebo-controlled, double-blind trial
Peng Xie, Tiannan Shao, Yujun Long, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access
Peng Xie, Tiannan Shao, Yujun Long, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access
Obesity mediates the relationship between depression and infertility: insights from the NHANES 2013-2018 cross-sectional study and a Mendelian randomization study
Ting Xu, Yuan Zhuang, Huabin Cao, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Ting Xu, Yuan Zhuang, Huabin Cao, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Effects of ketamine on metabolic parameters in depressive disorders: A systematic review
Sabrina Wong, Gia Han Le, Rodrigo B. Mansur, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 164-173
Open Access
Sabrina Wong, Gia Han Le, Rodrigo B. Mansur, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 164-173
Open Access